GenXys HealthCare Systems announces completion of oversubscribed seed round financing to enable continued market penetration with acclaimed precision prescribing software
GenXys provides evidence-based medication decision support tools with embedded pharmacogenetics to enable precision prescribing seamlessly at the point of care.
- GenXys provides evidence-based medication decision support tools with embedded pharmacogenetics to enable precision prescribing seamlessly at the point of care.
- The award-winning suite of clinical decision support software including TreatGx and ReviewGx is now interoperable with electronic health record systems and is pharmacogenetic test agnostic.
- GenXys, with global headquarters in Vancouver Canada, provides the world's most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare's biggest challenges; inappropriate ("trial-and-error") prescribing.
- Their clinical decision support software suite is in use by major insurance providers, health systems and pharmacies across North America.